33089-15-5

Basic information

• Product Name: 4-Chloro-2-(methylthio)pyrimidine-5-carbonitrile ,97%
• Synonyms: 4-Chloro-2-(methylthio)pyrimidine-5-carbonitrile ,97%;4-Chloro-2-(methylthio)pyrimidine-5-carbonitrile;4-Chloro-2-methylsulfanyl-pyrimidine-5-carbonitrile;4-Chloro-2-methylthio-5-cyanopyrimidine;4-Chloro-2-(methylthio)pyrimidine-5- carbonitrile 97%
• CAS NO: 33089-15-5
• Molecular Formula: C₆H₄ClN₃S
• Molecular Weight: 185.64
• EINECS: -0
• Mol File: 33089-15-5.mol
• Article Data: 7

Chemical Properties

• Melting Point: 67-68 °C(Solv: benzene (71-43-2); ligroine (8032-32-4))
• Boiling Point: 340.747 °C at 760 mmHg
• Flash Point: 159.878 °C
• Appearance: /
• Density: 1.459 g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.614
• Storage Temp.: Inert atmosphere,Store in freezer, under -20°C
• PKA: -3.26±0.29(Predicted)
• CAS DataBase Reference: 4-Chloro-2-(methylthio)pyrimidine-5-carbonitrile ,97%(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Chloro-2-(methylthio)pyrimidine-5-carbonitrile ,97%(33089-15-5)
• EPA Substance Registry System: 4-Chloro-2-(methylthio)pyrimidine-5-carbonitrile ,97%(33089-15-5)

Safety Data

• Statements: 20/21/22-36/37/38
• Safety Statements: 9-26-36/37
• RIDADR: 3439
• Hazardous Substances Data: 33089-15-5(Hazardous Substances Data)

Usage

Chemical Properties

White solid

InChI:InChI=1/C6H4ClN3S/c1-11-6-9-3-4(2-8)5(7)10-6/h3H,1H3

Upstream product

• 89487-99-0 4-hydroxy-2-methylsulfanylpyrimidine-5-carbonitrile 

Downstream Products

• 122773-92-6 4-Methoxy-2-methylsulfanyl-pyrimidine-5-carboximidic acid methyl ester; hydrochloride 
• 38275-43-3 2-(methylsulfanyl)pyrimidine-5-carbonitrile 
• 892413-67-1 3-[[5-cyano-2-(methylthio)-4-pyrimidinyl]amino]-benzoic acid 1,1-dimethylethyl ester 
• 892413-79-5 1-[[4-chloro-2-[[5-cyano-2-(methylthio)-4-pyrimidinyl]amino]5-fluorophenyl]methyl]-L-proline 1,1-dimethylethyl ester 
• 185040-27-1 4-(methylamino)-2-(methylsulfanyl)pyrimidine-5-carbonitrile 

Relevant articles and documents

SPAK/OSR INHIBITORS AND METHODS OF USING SAME

The present disclosure provides SPAK/OSR inhibitors. In certain embodiments, the compounds of the disclosure can be used to treat, ameliorate, and/or prevent certain cancers in a subject.

Pyrimidinyl pyridone inhibitors of kinases

This application discloses novel pyrimidinyl pyridone derivatives according to formula I, wherein A, R1, R2, R3, and m are defined as described herein, which inhibit JNK. The compounds disclosed herein are useful to modula

N-substituted nonaryl-heterocyclic NMDA/NR2B antagonists

Compounds represented by Formula (I): 1or pharmaceutically acceptable salts thereof, are effective as NMDA NR2B antagonists useful for relieving pain.